Japanese Oil and Gas Stock News

TSE:6098
TSE:6098Professional Services

A Look At Recruit Holdings (TSE:6098) Valuation As Board Weighs Future Share Repurchases

Board meeting on share repurchases puts Recruit Holdings in focus Recruit Holdings (TSE:6098) has called a board meeting for March 31, 2026, to decide on the status of its share repurchase plans, an item that often shapes how investors think about capital allocation. See our latest analysis for Recruit Holdings. At a share price of ¥7,361, Recruit Holdings has a 30 day share price return of 6.04%, while the year to date share price return of 18.39% and 1 year total shareholder return of...
TSE:3003
TSE:3003Real Estate

Will Hulic’s Strong Q1 2026 Revenue and EPS Gains Change Hulic's (TSE:3003) Narrative

Hulic Co., Ltd. recently reported first-quarter 2026 results, with sales rising to ¥226,841 million from ¥156,644 million and net income increasing to ¥18,141 million from ¥17,175 million a year earlier. Earnings per share from continuing operations also improved, suggesting that Hulic converted its higher revenue base into slightly stronger profitability for shareholders. We’ll now examine how Hulic’s robust year-over-year sales growth informs the company’s investment narrative and...
TSE:6728
TSE:6728Semiconductor

Does ULVAC’s Japan Furnace Expansion For Non‑China Magnets Change The Bull Case For ULVAC (TSE:6728)?

Earlier in 2026, ULVAC reported that orders for its continuous vacuum melting furnaces for rare-earth magnets are expected to roughly triple year on year, driven mainly by magnet manufacturers in Europe and North America building supply chains outside China. To capture this shift and reduce supply risk, ULVAC is adding a new production system in Japan, creating a dual-site furnace supply structure alongside its existing Chinese facility and placing itself at the center of emerging rare-earth...
TSE:5333
TSE:5333Machinery

NGK (TSE:5333) Is Up 15.7% After Solid FY2026 Earnings And Buyback Review Has The Bull Case Changed?

NGK Corporation recently reported full-year results for the period ended March 31, 2026, with sales of ¥670,125 million and net income of ¥59,936 million, and held a board meeting on April 30, 2026 to review the results of its share repurchase program. An interesting aspect of this update is the combination of solid reported earnings per share of about ¥206 and active capital management through the acquisition of its own shares. With these earnings figures and the share buyback review in...
TSE:6701
TSE:6701IT

Assessing NEC (TSE:6701) Valuation After Strong Full Year Earnings Results

Earnings snapshot and why this matters for NEC shareholders NEC (TSE:6701) has drawn fresh attention after reporting full year results to 31 March 2026, with sales of ¥3,582,733 million and net income of ¥270,228 million, alongside higher basic and diluted EPS from continuing operations. For existing and potential shareholders, these figures give an updated view of how NEC is converting its information technology and social infrastructure business into earnings, and how each share is...
TSE:9509
TSE:9509Electric Utilities

Board Weighs Higher Year-End Dividend Might Change The Case For Investing In Hokkaido Electric Power (TSE:9509)

Hokkaido Electric Power Company, Incorporated held a board meeting on April 28, 2026 to consider a notice regarding an increase in the year-end dividend from surplus. This focus on dividend policy is material for investors because shifts in payout decisions can reshape how the company’s capital allocation priorities are perceived. We will now examine how the potential year-end dividend increase could influence Hokkaido Electric Power’s broader investment narrative and appeal. We've uncovered...
TSE:7970
TSE:7970Chemicals

How Investors May Respond To Shin-Etsu Polymer (TSE:7970) Earnings Beat And Dividend Forecast Review

On April 27, 2026, Shin-Etsu Polymer Co., Ltd. reported full-year results for the period ended March 31, 2026, posting sales of ¥115,116 million and net income of ¥9,899 million, alongside basic earnings per share of ¥123.15 and diluted earnings per share of ¥122.28. At the same board meeting, the company moved to consider revising its dividend forecast for the fiscal year ending March 31, 2026, highlighting how earnings outcomes may influence its future shareholder payout policy. With the...
TSE:6857
TSE:6857Semiconductor

Assessing Advantest (TSE:6857) Valuation After Strong FY 2026 Results And New AI And HPC Initiatives

Why Advantest’s latest earnings matter for shareholders Advantest (TSE:6857) just reported full year sales of ¥1,128,610 million and net income of ¥375,353 million for the period to March 2026, alongside fresh product and partnership updates tied to AI and high performance computing. See our latest analysis for Advantest. Despite a 1-day share price return of 1.57% decline and a 7-day share price return of 5.52% decline, Advantest’s 30-day share price return of 31.67% and very large 1-year...
TSE:8060
TSE:8060Electronic

Canon Marketing Japan (TSE:8060) Valuation Check After Strong Q1 Results And Affirmed Dividend

Canon Marketing Japan (TSE:8060) is back on investors’ radar after its Q1 2026 results, reporting higher sales, net income, and earnings per share, along with full year guidance and dividend plans for 2026. See our latest analysis for Canon Marketing Japan. The stock’s 1 day share price return of 1.45% came after the Q1 earnings release. The 30 day and 90 day share price returns of 5.04% and 7.63% point to building momentum on top of a 47.45% 1 year total shareholder return. If Canon...
TSE:9433
TSE:9433Wireless Telecom

KDDI Faces TSE Governance Order What It Means For Long Term Investors

KDDI (TSE:9433) received a compliance and governance improvement order from the Tokyo Stock Exchange. The exchange also issued a listing rule violation penalty related to KDDI's governance and compliance practices. KDDI issued a public apology and stated it will strengthen governance and introduce measures to prevent a repeat of the issue. KDDI, a major Japanese telecom operator, sits at the center of mobile, broadband, and enterprise connectivity, where reliability and regulatory...
TSE:6902
TSE:6902Auto Components

DENSO Rethinks ROHM Deal And Future Power Semiconductor Positioning

DENSO, ticker TSE:6902, is reportedly considering withdrawing its acquisition proposal for power semiconductor maker ROHM. The potential withdrawal follows ROHM’s move to explore an integration with Toshiba and Mitsubishi Electric. This development affects earlier expectations around consolidation in Japan’s power semiconductor sector. DENSO is a major auto parts supplier with a growing focus on power semiconductors, which are used in electric vehicles, advanced driver assistance systems...
TSE:7261
TSE:7261Auto

Is Mazda Motor (TSE:7261) Still Attractive After Recent Share Price Weakness?

If you are wondering whether Mazda Motor's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock last closed at ¥1,008.5, with a 1.5% decline over the past week and a 3.5% decline over the past month, while still showing a 21.4% return over the past year and 40.4% over five years. Recent coverage has focused on Mazda Motor's share price performance over different time frames, highlighting the...
TSE:1803
TSE:1803Construction

Shimizu (TSE:1803) Is Up 6.4% After Upgrading FY2026 Guidance And Dividend Outlook – Has The Bull Case Changed?

Shimizu Corporation recently raised its consolidated and non-consolidated earnings guidance for the fiscal year ending March 31, 2026, projecting net sales of ¥2.06 billion and higher operating and net income, supported by stronger domestic construction activity and an expected special gain from acquiring Aomi Construction as a subsidiary. The company also lifted its full-year dividend forecast to ¥50.00 per share, signaling management’s confidence in the improved profitability of its...
TSE:4503
TSE:4503Pharmaceuticals

Astellas Pharma (TSE:4503) Is Down 10.6% After Earnings Rebound And PADCEV Milestone – Has The Bull Case Changed?

Astellas Pharma Inc. recently reported full-year results to March 31, 2026, with sales rising to ¥2.14 trillion and net income to ¥291.54 billion, alongside an FDA Priority Review for a broader PADCEV plus Keytruda indication in muscle-invasive bladder cancer. Together with upcoming retinal-disease data presentations and board-level changes under consideration, these developments underscore how oncology and ophthalmology innovation are increasingly central to Astellas’ business mix. We’ll...